---
canonical_url: https://www.stockexpertai.com/earnings/cvx
last_updated: 2026-05-03T20:42:35.443Z
---

# Chevron Corporation (CVX) Q1 FY2027 Earnings Preview

> This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-03T20:42:34.221Z. Educational tool, not investment advice.

---

## Quick Summary

| Field | Value | Source |
|---|---|---|
| Price | $190.63 (▼ -1.39%) | fmp:quote |
| Market Cap | $380.4B | fmp:profile |
| 52w range | $133.77 – $214.71 | fmp:quote |
| Earnings | Fri 7 Aug | fmp:earnings-history |
| EPS estimate | $4.53 (+156% YoY) | fmp:earnings-estimate |
| Revenue estimate | $60.0B | fmp:earnings-estimate |
| Beat streak | 5/4 | fmp:earnings-history |
| Rating | B (overall 3/5) | fmp:ratings |
| Analyst median target | $190 (-0.6% upside) | fmp:price-target-consensus |
| MoonshotScore | 33/100 | derived |
| Council | 0/6 bullish | derived |
| Munger verdict | Overvalued | derived |

## Chevron Corporation — Q1 FY2027 Expectations

Q1 consensus: revenue <strong data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvgLabel">$60.0B</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.revenueAvg" title="FMP est">[FMP est]</sup>, EPS <strong data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">$4.53</strong><sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg" title="FMP est">[FMP est]</sup>. 5 consecutive quarters of beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.beatStreakCount" title="FMP earnings">[FMP earnings]</sup>.

## Quick Take

**Score:** B · **Stance:** SELL · **Council:** 0/6 · **Moonshot:** 33

= MoonshotScore <strong>33</strong><sup class="cite" data-source="derived" data-field="moonshot.score" title="9-pillar formula">[9-pillar formula]</sup> + Council <strong>0/6</strong><sup class="cite" data-source="derived" data-field="council.bullishCount" title="6-lens rule">[6-lens rule]</sup>. Form 4: 0 transactions<sup class="cite" data-source="fmp:insider-trading" data-field="insider.txCount" title="FMP Form 4">[FMP Form 4]</sup>.

## Watchlist (5 metrics)

### 1. Venezuela Cash Flow

Chevron expects Venezuela to continue to represent 1% to 2% of cash flow from operations.

> "We are still in debt recovery mode and expect Venezuela to continue to represent 1% to 2% of cash flow from operations."
> — Michael K. Wirth, CEO, Investor Focus · Q1 FY2026

### 2. Production Increase

First-quarter 2026 oil-equivalent production increased by approximately 500 thousand barrels per day compared to 2025.

> "First-quarter 2026 oil-equivalent production increased by approximately 500 thousand barrels per day compared to 2025."
> — Eimear P. Bonner, CFO, Investor Focus · Q1 FY2026

### 3. Unfavorable Timing Effects

Chevron's first-quarter earnings were impacted by approximately $3 billion of unfavorable timing effects, reflecting a steep rise in commodity prices in March.

> "Unfavorable timing effects totaled around $3 billion for the quarter, reflecting a steep rise in commodity prices in March."
> — Eimear P. Bonner, CFO, Investor Focus · Q1 FY2026

### 4. Global Equity Crude Throughput

Chevron expects global equity crude throughput to more than double year over year to 40% in the second quarter.

> "In the second quarter, we expect global equity crude throughput to more than double year over year to 40%."
> — Michael K. Wirth, CEO, Investor Focus · Q1 FY2026

### 5. Asia Refinery Utilization

Chevron anticipates over 80% refinery utilization in Asia.

> "In Asia, we anticipate over 80% refinery utilization."
> — Michael K. Wirth, CEO, Investor Focus · Q1 FY2026


## MoonshotScore Pillars

| Pillar | Score | Level | Evidence |
|---|---|---|---|
| Revenue Growth | 4.0 | medium | Q1 vs Q2: moderate growth (+7.2%) |
| Gross Margin | 1.0 | weak | Q1: low margin (9.6%, capital-intensive or commodity) |
| Operating Leverage | 1.0 | weak | op margin average (6.8%) |
| Cash Runway | 3.0 | weak | FCF negative ($-1.5B, external financing needed) |
| R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) |
| Price Momentum | 4.0 | medium | RSI 49.9 balanced, 50d below |
| News Sentiment | 7.0 | strong | strong buy consensus (72%) |

**Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula.

## Council (7-Lens)

| Name | Stance | Context |
|---|---|---|
| Ray Dalio | neutral | macro · target upside -0.6% |
| Ken Griffin | bear | flow · 50d MA below |
| Jim Simons | neutral | quant · RSI 50 |
| Klarman | bear | value · target upside -0.6% |
| Buffett | neutral | quality · ROE score 3/5 |
| Munger | bear | valuation · target upside -0.6% |

**Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr.

## Munger Lens

- **Verdict:** Overvalued
- **Financial Health:** Moderate
- **Margin of Safety:** Weak
- **Interest Coverage:** Adequate
- **ROIC vs WACC:** Tight

**Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget.

## Technical Levels

- **RSI(14):** 49.9 — dengeli — yön sinyali zayıf
- **50d MA:** $193 — hisse %1.2 altında — kısa vadeli direnç
- **200d MA:** $167 — hisse %14.5 üstünde — uzun vadeli destek
- **Volume (10d):** +8%

## Past Performance (4 Quarters)

| Quarter | EPS Actual | EPS Estimate | Result | Reaction |
|---|---|---|---|---|
| Q2 FY25 | $1.77 | $1.73 | BEAT | -0.2% |
| Q3 FY25 | $1.85 | $1.69 | BEAT | -2.3% |
| Q4 FY25 | $1.52 | $1.41 | BEAT | -1.6% |
| Q1 FY26 | $1.41 | $1.00 | +41.0% EPS | no data |

Q1 (May 1, 2026): EPS $1.41 vs $1.00 est<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, +41.0% beat. D+1 movement: no data<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP D+1">[FMP D+1]</sup>. Decline despite beat — market reacted to guidance, not numbers.

## 3 Scenarios

### Scenario A · Beat
**Q1 EPS > $4.53 + CapEx discipline**

Threshold: EPS > $4.53<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>.

Target: Break above median target $190<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP target]</sup>; high target $222<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.high">[FMP]</sup> upper bound.

### Scenario B · In-Line
**EPS ≈ $4.53 + CapEx < $4.1B**

Threshold: EPS ≈ $4.53<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est]</sup>, Q1 CapEx < $4.1B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel">[FMP]</sup>.

Target: Consolidation in the band between current $191<sup class="cite" data-source="fmp:quote" data-field="quote.price">[FMP]</sup> and median $190<sup class="cite" data-source="fmp:price-target-consensus" data-field="priceTarget.median">[FMP]</sup>.

### Scenario C · Miss
**EPS < $4.39 or CapEx ≥ $4.1B**

Threshold: EPS < $4.39<sup class="cite" data-source="fmp:earnings-estimate" data-field="estimates.next.epsAvg">[FMP est×0.97]</sup>.

Target: Current $191 below SMA200 $167<sup class="cite" data-source="fmp:technical" data-field="technical.sma200">[FMP]</sup>, if rejection continues, $142<sup class="cite" data-source="derived" data-field="technical.sma200" data-formula="round(sma200*0.85)">[derived]</sup> support activates.

## Risk Notes

### Primary segment below threshold
Q1: EPS $1.41 vs $1.00 beat<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.history.0" title="FMP">[FMP]</sup>, stock no data D+1<sup class="cite" data-source="fmp:earnings-history" data-field="earnings.timeline.3.reactionLabel" title="FMP">[FMP]</sup>.

### Backlog concentration
No RPO/backlog concentration disclosed in Q1 earnings call.

### Insider trading
Form 4 data is marked in the table — this page does not generate assumptions for this stock.

| Executive | Action | Amount | Date |
|---|---|---|---|


**Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26

### CapEx shock
Q1 CapEx $4.1B<sup class="cite" data-source="fmp:cashflow" data-field="cashflow.qPrev.capexLabel" title="FMP cashflow">[FMP cashflow]</sup>. Q1 op margin 6.8%<sup class="cite" data-source="fmp:income" data-field="income.quarters.0.operatingMargin" title="FMP op margin">[FMP op margin]</sup> — this level in Q1 is sensitive to CapEx revision risk.

## Wall Street Consensus

- **Median target:** $190 (-0.6% upside vs current $191)
- **High / Low:** $222 / $166
- **Buy / Hold / Sell:** 18 / 6 / 1
- **Analyst count:** 4 (last quarter), 105 all-time

## Additional Transcript Insights

### 1. integration_benefits

**Claim:** Chevron Corporation realized significant integration benefits during the quarter due to its high-quality upstream and downstream portfolios.

**Evidence (transcript):** "Our high-quality upstream and downstream portfolios delivered significant integration benefits during the quarter."

**Numbers:** —

### 2. global_equity_crude_throughput

**Claim:** Chevron expects global equity crude throughput to more than double year over year to 40% in the second quarter.

**Evidence (transcript):** "In the second quarter, we expect global equity crude throughput to more than double year over year to 40%."

**Numbers:** 40%

### 3. asia_refinery_utilization

**Claim:** Chevron anticipates over 80% refinery utilization in Asia.

**Evidence (transcript):** "In Asia, we anticipate over 80% refinery utilization."

**Numbers:** 80%

### 4. venezuela_cash_flow

**Claim:** Chevron expects Venezuela to continue to represent 1% to 2% of cash flow from operations.

**Evidence (transcript):** "We are still in debt recovery mode and expect Venezuela to continue to represent 1% to 2% of cash flow from operations."

**Numbers:** 1%, 2%

### 5. unfavorable_timing_effects

**Claim:** Chevron's first-quarter earnings were impacted by approximately $3 billion of unfavorable timing effects, reflecting a steep rise in commodity prices in March.

**Evidence (transcript):** "Unfavorable timing effects totaled around $3 billion for the quarter, reflecting a steep rise in commodity prices in March."

**Numbers:** $3 billion

### 6. production_increase

**Claim:** First-quarter 2026 oil-equivalent production increased by approximately 500 thousand barrels per day compared to 2025.

**Evidence (transcript):** "First-quarter 2026 oil-equivalent production increased by approximately 500 thousand barrels per day compared to 2025."

**Numbers:** 500 thousand


---

*Data source: FMP (live query, 2026-05-03), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*
